SG Americas Securities, LLC

Broker-Dealer

Position in SVRA — Savara Inc

CIK 1313360 NEW YORK, NY

Position in SVRA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$381,778

+$68,374 QoQ

Shares Held

61,977

+8.0% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#96

of 181 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. SVRA ranks #108 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$381,778	61,977	+8.0%	Shares	Sole	2026-08-07
2026-03-31	$313,404	57,400	+26.1%	Shares	Sole	2026-04-16
2025-12-31	$274,521	45,526	-32.1%	Shares	Sole	2026-01-09
2025-03-31	$185,850	67,094	+30.1%	Shares	Sole	2025-04-15
2024-12-31	$158,378	51,589	+14.0%	Shares	Sole	2025-01-17
2024-09-30	$191,898	45,259	+34.2%	Shares	Sole	2024-10-03
2024-03-31	$167,910	33,717	-32.4%	Shares	Sole	2024-05-06
2023-12-31	$234,351	49,862	+34.2%	Shares	Sole	2024-01-12
2023-09-30	$140,396	37,142	+198.9%	Shares	Sole	2023-10-13
2020-12-31	$14,288	12,425	+20.5%	Shares	Sole	2021-02-04
2020-09-30	$11,235	10,308	-59.3%	Shares	Sole	2020-11-09
2020-06-30	$63,059	25,325	+103.4%	Shares	Sole	2020-07-20
2020-03-31	$26,389	12,448	—	Shares	Sole	2020-04-30
No filing history on record for this holder in this stock.